Hjem › Multipelt myelom › Virginia › Arlington
Multipelt myelom kliniske forsøg i Arlington, VA
9 studier for Multipelt myelom søger deltagere på steder i og omkring Arlington (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RekruttererFase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 278716, Fairfax · 11 mi væk
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi væk
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekruttererFase 1/2
- Research Site, Fairfax · 11 mi væk
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Fairfax · 11 mi væk
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi væk
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Fairfax · 11 mi væk
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekruttererFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi væk
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi væk
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RekruttererFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi væk
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Arlington
- Ikke-småcellet lungecancer104 studier
- Metastatisk cancer53 studier
- Colorektal kræft52 studier
- Kræft (alle typer)48 studier
- Brystkræft46 studier
- Ægstockræft46 studier
- Lungecancer41 studier
- Livmoderslimhindekræft39 studier
- Bugspytkirtelkræft33 studier
- Pladecellekræft i hoved og hals26 studier
- Småcellet lungekræft23 studier
- Tripelnegativ brystkræft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.